Welcome to the Virtual MS Center!
Ask any question you want about Multiple Sclerosis and one of our experts will answer it as soon as possible.
|
Here is My Question:
Do you have a virtual physical therapy? Answer: Yes, we work with the Adapt Functional Movement Center in Carlsbad, California who provides a host of virtual therapy options. For 1-on-1 sessions, their team uses a practice called Functional Movement Therapy, which is specifically designed to maintain nervous system activity in order to preserve and strengthen function. The team at Adapt uses the neurodevelopmental sequence in their Functional Movement Therapy, which is the normal movement progression that infants follow as they grow and develop the abilities to roll, crawl, stand, and walk. That same sequence provides direction in the rehabilitation field by giving the team a logical series of postures and movement strategies to follow in order to re-educate the nervous system. Adapt works heavily with MS patients as well as a host of other neurological and neurodegenerative conditions and offers programs onsite at their center in California, as well as virtually over Zoom. They also conduct a series of live classes and activities on a weekly basis which are free for members of the organization. You can get more information at www.adaptmovement.org The HealthCare Journey Team
0 Comments
Here is My Question:
I had a urinalysis done this week prior to my scheduled infusion of Ofatumumab. My urine culture came back positive for a UTI. I have no UTI symptoms, but have had flare ups of past MS related symptoms and headaches for the last week. My question is, how common is it to have an asymptomatic UTI? I have never had one (that I know of) before. I’m 33, diagnosed with RRMS in October, take no other medications and have no other medical conditions. Would it be helpful to take any supplements (cranberry) to help prevent future UTIs? Answer: Your can categorize bacteriuria (i.e bacteria in the urine) into four categories for people with Multiple Sclerosis :
Overall, risk factors for asymptomatic or symptomatic UTIs in people with MS include being female, older, more disabled (at least walking with assistance), prior UTIs and using catheters. In your case, I do not have enough information to determine if your positive results were caused by contamination or an asymptomatic urinary tract infection. If both your urinalysis and urine culture showed signs of an acute infection then this likely represents an asymptomatic UTI. Revere P (Rip) Kinkel, MDProfessor of Clinical Neurosciences Director of the Multiple Sclerosis Program Clinical Neurosciences Director University of California San Diego Dear Health Care Journey Readers As we begin to gradually open up society and venture out once again to areas where we can get exposed to COVID 19, it is important to understand the relative risks for exposure in different environmental situations and make sure that we minimize these risks. Several days ago I read the enclosed Blog post by Erin Bromage, PhD, an immunologist specializing in infectious diseases and vaccines at the University of Massachusetts. Dr Bromage does such a fantastic job of reviewing this topic that I thought I should share this with you. Please pass this along to friends, colleagues and family members. Stay safe Revere P (Rip) Kinkel, MDProfessor of Clinical Neurosciences Director of the Multiple Sclerosis Program Clinical Neurosciences Director University of California San Diego 
Here is My Question:
With COVID-19, I completed my Ocrevus treatment April 2019, I haven't gotten a boost since then. Is it safe to travel? Safe to get on a plane? Answer: The answer to this question depends on your risk factors, where you plan to travel and what you plan to do once you arrive at your location? The main risk factors for serious COVID 19 infections, including death, include age over 60 (especially males), hypertension, diabetes, obesity, vascular disease and significant disability. If you have any of these risk factors you should still be in quarantine at home. If you do not have significant risk factors, I would consider travel only if absolutely necessary and take precautions. We do not at present know if ocrelizumab increases the risk of more severe COVID-19 infections. If your naive B cells have returned, which is usually the case 6 to 12 months after an ocrevus infusion cycle, you will theoretically be able to develop a humoral immune response against a novel pathogen like COVID-19. Revere P (Rip) Kinkel, MD Professor of Clinical Neurosciences Director of the Multiple Sclerosis Program Clinical Neurosciences Director University of California San Diego What is the risk of returning to work in a major hospital after receiving anti-CD20 therapy?5/22/2020 Question: What is the risk of returning to work in a major hospital after receiving anti-CD20 therapy?
Answer: We do not have much information to guide us at present but here is what we know:
Generally, I recommend that patients with MS on Ocrevus who work in healthcare get transferred to duties with decreased patient interaction, if they are young and have no other risk factors for severe COVID-19 infection. If a person has multiple known risk factors in addition to receiving treatment with COVID 19, I recommend a leave of absence from work until there is a steady decline in cases to the health facility for over 2 weeks and then allow a return to work initially to duties with decreased patient interaction. In all cases workers should follow social distancing rules with adequate PPE and frequent cleaning of hands and equipment. I hope this helps Revere P (Rip) Kinkel, MD Professor of Clinical Neurosciences Director of the Multiple Sclerosis Program Clinical Neurosciences Director University of California San Diego Here is My Question:
I've been on Tysabri for 7 years. Every 4 weeks I get an infusion. Now my neurologist has put me on 6 weekly infusions which is not my choice. I've never felt this way in 7 years...I feel light headed, sick, tired and I've no motivation. Help! Answer: There are many potential reasons for feeling, "lightheaded, sick and tired" , that have nothing to do with extending the interval between infusions to every 6 weeks. Talk to your doctor to see if he or she can provide an answer. Most current evidence suggests that people receiving tysabri every 6 weeks do just as well as those receiving every 4 week tysabri. There is a clinical trial underwent to make sure there is no difference in outcomes between patients randomly assigned to continue on every 4 week tysabri or increase the interval between infusions to every 6 weeks, but the results are not available at present. If you are JCV antibody negative, you could simply ask your neurologist if it is okay to return to every 4 week infusions, if you and your doctor are convinced your problems are related to the change in schedule. Good luck Revere P (Rip) Kinkel, MD Professor of Clinical Neurosciences Director of the Multiple Sclerosis Program Clinical Neurosciences Director University of California San Diego Due to COVID-19 we are cancelling the MS Expo that had been scheduled for June 6th. We apologize for any inconvenience. However, we are making some exciting plans for future events so please stay tuned! Have a very happy and healthy Memorial Day weekend!
Best, The HeathCare Journey Team Here is My Question:
I have constant stomach and bowel issues & I can’t seem to get any answers if this is MS related & what to do if it is. I am 62 years old & was officially diagnosed with MS in early 2018 although I have had symptoms for years prior to being diagnosed. Thanks. Answer: Stomach and bowel "issues" could refer to many things. Your doctor will need to determine the following:
Revere P (Rip) Kinkel, MD Professor of Clinical Neurosciences Director of the Multiple Sclerosis Program Clinical Neurosciences Director University of California San Diego Here is My Question:
Is nerve damage causing numbness in my feet to turn into pain? Last year, I had a lesion on my spine that caused numbness from the waist down. After steroid treatment it gradually subsided and I am able to walk safely again. However, my feet feel mildy numb when I first get up. It subsides but gets much worse when I walk for more than 45 minutes at a time. If I am at work, where I am standing all day, the numbness becomes very painful. Usually 4 or 5 hours into my shift it starts to hurt. Some days I can't make it until the end of my shift. It feels like my feet are being crushed by a steamroller! I usually sit in the break room for at least an hour before I feel like I can make it to my car. Would it make sense to assume the pain is the result of pushing too much, past the numbness? Answer: You are describing neuropathic pain which can be caused by nerve damage (possibly from the spinal cord or peripheral nerves running to your feet in your case). I'd recommend you speak with your neurologist about your symptoms to help determine the cause but also potential treatment to help take the edge off your neuropathic pain so you can function better at work. A. Scott Nielsen MD MMSc Neurologist and MS Specialist at Kaiser Permanente Here is My Question:
I just started taking Tecfidera today. I took it around 11 am, and made sure to eat healthy fats with it (my doctor recommended this). I was fine up until 3:30-3:45, and then the flushing kicked in. I was wondering if eating certain foods may cause flushing? I know this is a side effect of the medication, but I ate some spicy chili at 3, and then the flushing started. I was fine all day up until then. Other than that I've had no other side effects (cross my fingers). Answer: Flushing is a common side effect of Tecfidera. Clinical trials 36% of people taking dimethyl fumarate reported experiencing flushing and 42% reported gastrointestinal (GI) upset such as nausea, vomiting, abdominal pain or diarrhea. These side effects tend to occur in the first month or so of treatment before easing off, however they can be troublesome to deal with and it is known that experiencing these symptoms can affect how many people stay using treatment. If side effects such flushing or GI upset can be effectively managed then it is likely more people will continue dimethyl fumarate treatment and benefit from its disease modifying effects.The suggested strategies to reduce the impact and severity of flushing and GI upset include:
Clinical Associate Professor of Neurology Liaison for Neurology, Fort Collins Branch University of Colorado Denver School of Medicine Here is My Question:
Now that places are opening up, in Florida restaurants can open at 25%, is it safe for my 80 yr old husband, in a wheelchair with MS to go to dinner? Answer: In New York City, where we have the best data currently on COVID-19 outcomes, the mortality rate in people over age 75 is very high compared to other age groups. In fact mortality rates start to increase every decade after age 40 For instance, the chance that a person over the age of 75 will die from a COVID 19 infection is 75 fold higher than the chance of death for a person under the age of 45 and 8 fold higher than the chance of death for a person between the age of 45 and 64. Revere P (Rip) Kinkel, MDProfessor of Clinical Neurosciences Director of the Multiple Sclerosis Program Clinical Neurosciences Director University of California San Diego Here is My Question:
I am 55 years old and was diagnosed with multiple sclerosis 5 years ago. My first symptoms started more than 15 years ago but I was not diagnosed with the disease at the time. After my diagnosis I was put on Tecfidera and have been on the medication since then. It has done a good job controlling my disease. I have had no side effects while on the medication. I had a recent worsening of symptoms that improved within 4 days. I had an MRI scan done and there were minimum new changes that do not explain my complaint. My doctor thinks that it might have been a pseudo relapse, or that I could be transitioning into the secondary progressive form given the length of my disease activity (more than 15 years now). Here are my questions:
Answer: Thank you for your question and providing the great amount of detail about your case To summarize:
The easy answer is just to stay on the Tecfidera and monitor more frequently by Quantitative Clinical Performance Evaluations and another MRI in 6 months. Going forward I encourage you and everyone reading this post to thoroughly consider your goals or treatment and decide ahead of time what it would take for you to consider changing that treatment. To answer your other questions 2. There is no particular reason for a wash out period if your lab values, specifically your absolute lymphocyte count is above the lower limit of normal range 3. I have heard nothing in your report to suggest you have SPMS. 4. Ocrevus is a great drug. We have no evidence from your experience that either Mayzent or Ocrevus would be a better drug for you than the current tecfidera Of course, your doctor knows your case better than I do and may have other information that you (and I) are not aware on which he or she is basing their recommendations. I would encourage you to have a full discussion with him or her about all the reasons for this recommendation to change therapy. Make them defend this decision. Since we are not curing MS yet, we expect occasional hiccups and one every 5 years that last 4 days is not a major decision making event. Thank you for your question and providing the great amount of detail about your case Revere P (Rip) Kinkel, MDProfessor of Clinical Neurosciences Director of the Multiple Sclerosis Program Clinical Neurosciences Director University of California San Diego Here is My Question:
I have been getting Ocrevus for about two years and think I had Covid 19 a month ago. I was never tested for it. Would the antibody test for Covid 19 be accurate for me, or would the Ocrevus affect the results? Answer: Antibody test results for COVID 19 should not be affected by treatment with Ocrevus unless you are severely deficient in immunoglobulin. For instance, Ocrevus treatment does not affect other antibody test results in most patients. Revere P (Rip) Kinkel, MDProfessor of Clinical Neurosciences Director of the Multiple Sclerosis Program Clinical Neurosciences Director University of California San Diego |
PLEASE NOTE: This information/opinions on this site should be used as an information source only. This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.
Archives
March 2023
Categories
All
|
||
RSS Feed
